Home > Journals > Minerva Urology and Nephrology > Past Issues > Minerva Urology and Nephrology 2021 August;73(4) > Minerva Urology and Nephrology 2021 August;73(4):549-51

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

EDITORIAL COMMENT   

Minerva Urology and Nephrology 2021 August;73(4):549-51

DOI: 10.23736/S2724-6051.21.04605-X

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Renal tumors ablation

Michele MARCHIONI 1, 2, Daniele AMPARORE 3 , Alexandre INGELS 4, 5, Umberto CARBONARA 6, Angela PECORARO 3, Eduard ROUSSEL 7, Riccardo CAMPI 8, 9, on behalf of the European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group

1 Laboratory of Biostatistics, Department of Medical, Oral and Biotechnological Sciences, G. D’Annunzio University, Chieti, Italy; 2 Department of Urology, SS Annunziata Hospital, G. D’Annunzio University, Chieti, Italy; 3 School of Medicine, Division of Urology, Department of Oncology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy; 4 Department of Urology, APHP, Henri Mondor University Hospital, Créteil, France; 5 Biomaps, UMR1281, INSERM, CNRS, CEA, Paris Saclay University, Villejuif, France; 6 Unit of Andrology and Kidney Transplantation, Department of Emergency and Organ Transplantation-Urology, University of Bari, Bari, Italy; 7 Department of Urology, University Hospitals of Leuven, Leuven, Belgium; 8 Unit of Urological Robotic Surgery and Renal Transplantation, University of Florence, Careggi Hospital, Florence, Italy; 9 Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy



top of page